Ceacam1 is related with insulin resistance, and its liver-specific deletion can lead to chronic hyperinsulinemia, impaired insulin clearance, hepatic insulin resistance and steatosis (Ghadieh et al., 2019). This evidence concerns the gene INS and Insulin resistance.